Annual Reportable Labeling Changes for New Drug Applications and Abbreviated New Drug Applications for Nonprescription Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 13, 2024
March 13, 2024
d9b364f3-3dda-4016-b1bb-5c4149f0f32b
Related Documents
Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs
Guidance DocumentApril 29, 2024Center for Drug Evaluation and Research
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Innovative Approaches for Nonprescription Drug Products
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.